Peer-reviewedCC BY-NC-ND 4.0Communications Biology
SGLT2 inhibitors attenuate diabetic kidney disease by suppressing YAP dependent ferroptosis
Related
- USP25 promotes ferroptosis in diabetic retinopathy by deubiquitinating p53 and suppressing the GPX4/SLC7A11 axis
- Resveratrol attenuates tubular injury in diabetic kidney disease by suppressing the ferroptosis–ferritinophagy pathway
- PEGylated nicotinamide mononucleotide targeted ferroptosis in acute kidney injury by suppressing FAR1 palmitoylation in an ACAA1-dependent manner.
- Vitamin K1-Loaded Poly(Lactic-Co-Glycolic Acid)-Polyethylenimine Nanoparticles Promote Diabetic Wound Healing through FSP1-Dependent Suppression of Ferroptosis
- M2 macrophage-derived exosomes and miR-132-3p promote gastric cancer cell aggressiveness and attenuate ferroptosis-related changes
BibTeX
@article{feng2026sglt2,
title = {{SGLT2 inhibitors attenuate diabetic kidney disease by suppressing YAP dependent ferroptosis}},
author = {Lan Feng and Chunni Feng and Huirong Li and Tingting Wang and Han Zhang and Yixiao Zhao and Hongbao Liu},
journal = {Communications Biology},
year = {2026},
month = oct,
doi = {10.1038/s42003-026-11227-3},
url = {https://www.nature.com/articles/s42003-026-11227-3},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - SGLT2 inhibitors attenuate diabetic kidney disease by suppressing YAP dependent ferroptosis
AU - Lan Feng
AU - Chunni Feng
AU - Huirong Li
AU - Tingting Wang
AU - Han Zhang
AU - Yixiao Zhao
AU - Hongbao Liu
PY - 2026
DA - 2026/10/19
JO - Communications Biology
DO - 10.1038/s42003-026-11227-3
UR - https://www.nature.com/articles/s42003-026-11227-3
SN - 2399-3642
ER -